Wealthfront Advisers LLC Invests $2.93 Million in ICU Medical, Inc. (NASDAQ:ICUI)

Wealthfront Advisers LLC acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 18,873 shares of the medical instruments supplier's stock, valued at approximately $2,929,000. Wealthfront Advisers LLC owned approximately 0.08% of ICU Medical at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of ICUI. Venturi Wealth Management LLC boosted its position in ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock valued at $59,000 after purchasing an additional 302 shares during the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of ICU Medical in the 3rd quarter valued at approximately $72,000. Smartleaf Asset Management LLC boosted its holdings in shares of ICU Medical by 166.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after buying an additional 567 shares during the last quarter. Coldstream Capital Management Inc. bought a new position in shares of ICU Medical in the third quarter valued at $227,000. Finally, OLD National Bancorp IN increased its holdings in ICU Medical by 22.0% during the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier's stock worth $227,000 after buying an additional 264 shares during the last quarter. Institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Jefferies Financial Group raised shares of ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price objective for the company in a research report on Wednesday, December 11th. StockNews.com cut ICU Medical from a "buy" rating to a "hold" rating in a report on Monday, March 10th. Finally, Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, ICU Medical has a consensus rating of "Moderate Buy" and a consensus price target of $168.67.

Remove Ads

Insider Buying and Selling at ICU Medical

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 6.70% of the company's stock.

ICU Medical Stock Performance

Shares of ICUI traded up $5.76 during trading hours on Monday, hitting $149.21. The company had a trading volume of 208,710 shares, compared to its average volume of 233,040. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of -32.65 and a beta of 0.73. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The business has a fifty day moving average of $157.27 and a 200-day moving average of $164.97. ICU Medical, Inc. has a 12 month low of $93.36 and a 12 month high of $196.26.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.